Evidence map›Paper›PMID 38124338›Full record

ReviewGenetics2024

Bone morphogenetic protein signaling: the pathway and its regulation.

Takuya Akiyama, Laurel A Raftery, Kristi A Wharton

Abstract readReview
In one paragraph

Review in Genetics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Robinow syndrome DVL1 variants disrupt morphogenesis and appendage formation in a Drosophila disease model.Developmental dynamics : an official publication of the American Association of Anatomists · 2026
    Article
  5. Article
  6. Article
  7. Niche-dependent modular regulation of the stem cell transcriptome separates cell identity and potential.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Takuya AkiyamaDepartment of Biology, Rich and Robin Porter Cancer Research Center, The Center for Genomic Advocacy, Indiana State University, Terre Haute, IN 47809, USA.
Laurel A RafterySchool of Life Sciences, University of Nevada, 4505 S. Maryland Parkway, Las Vegas, NV 89154, USA.ORCID 0000-0003-4797-4163
Kristi A WhartonDepartment of Molecular Biology, Cell Biology, and Biochemistry, Carney Institute for Brain Science, Brown University, Providence, RI 02912, USA.ORCID 0000-0001-9625-4336

Funding

Differential regulation of BMP Signals in VivoR01GM068118 · NIGMS · BROWN UNIVERSITY · PI WHARTON, KRISTI A · 2005 to 2014
$2.5M
Regulated energy metabolism in ALS/FTDRF1NS126667 · NINDS · BROWN UNIVERSITY · PI WHARTON, KRISTI A · 2022 to 2022
$1.2M
Differential regulation of BMP signals in vivo.R56GM068118 · NIGMS · BROWN UNIVERSITY · PI WHARTON, KRISTI A · 2009 to 2009
$352k
NIGMS NIH HHS R01 GM068118NIGMS NIH HHS R56 GM068118NINDS NIH HHS RF1 NS126667
6 · The paper itself

Abstract

In the mid-1960s, bone morphogenetic proteins (BMPs) were first identified in the extracts of bone to have the remarkable ability to induce heterotopic bone. When the Drosophila gene decapentaplegic (dpp) was first identified to share sequence similarity with mammalian BMP2/BMP4 in the late-1980s, it became clear that secreted BMP ligands can mediate processes other than bone formation. Following this discovery, collaborative efforts between Drosophila geneticists and mammalian biochemists made use of the strengths of their respective model systems to identify BMP signaling components and delineate the pathway. The ability to conduct genetic modifier screens in Drosophila with relative ease was critical in identifying the intracellular signal transducers for BMP signaling and the related transforming growth factor-beta/activin signaling pathway. Such screens also revealed a host of genes that encode other core signaling components and regulators of the pathway. In this review, we provide a historical account of this exciting time of gene discovery and discuss how the field has advanced over the past 30 years. We have learned that while the core BMP pathway is quite simple, composed of 3 components (ligand, receptor, and signal transducer), behind the versatility of this pathway lies multiple layers of regulation that ensures precise tissue-specific signaling output. We provide a sampling of these discoveries and highlight many questions that remain to be answered to fully understand the complexity of BMP signaling.

Indexed as

Drosophila ProteinsAnimalsBone Morphogenetic ProteinsDrosophilaGene Expression Regulation, DevelopmentalMammalsSignal TransductionTransforming Growth Factor betaBone Morphogenetic Proteinsdpp protein, DrosophilaDrosophila ProteinsTransforming Growth Factor betaBMP signalingDppDV patterningFlyBookGbbmorphogen gradientNMJSaxTkvwing patterning

Identifiers

PMID38124338
PMCPMC10847725

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.